National Leadership in Fontan Outcomes Research - Takeaway - MDSpire
Clinical Guidelines

National Leadership in Fontan Outcomes Research

  • April 1, 2026

  • 2 min

Share

  • 1

    The study analyzed 1,121 patients with complex congenital heart disease.

  • 2

    60% faced Fontan-related adverse events.

  • 3

    41% experienced arrhythmias, which increased with age.

  • 4

    58% had acquired comorbidities, including asthma.

  • 5

    Over a third of the participants had anxiety-related disorders.

  • 6

    Antithrombotic therapy was widely used among participants.

  • 7

    Phoenix Children’s became a leading contributor to the Fontan Outcomes Network.

  • 8

    Coordinated care is crucial for this patient population.

Original Source(s)